VTP50469
VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction (Ki: 104 pM) and has potently anti-leukemia activity.
Product Specifications
CAS Number
2169916-18-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
630.82
Molecular Formula
C32H47FN6O4S
Notes
Research use only, not for human use.
Receptor
Apoptosis|Menin-MLL interaction
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS960502-01 0.02 mg (E-Coli)
Recombinant Human Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
Sign In for Pricing
View Details MBS960502-02 0.1 mg (E-Coli)
Recombinant Human Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
Sign In for Pricing
View Details MBS960502-03 1 mg (E-Coli)
Recombinant Human Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
Sign In for Pricing
View Details MBS960502-04 5x 1 mg (E-Coli)
Recombinant Human Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
Sign In for Pricing
View Details